Windtree Therapeutics Inc
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 sur… Read more
Market Cap & Net Worth: Windtree Therapeutics Inc (WINTW)
Windtree Therapeutics Inc (PINK:WINTW) has a market capitalization of $86.53 ($86.53) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38472 globally and #12514 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Windtree Therapeutics Inc's stock price $0.01 by its total outstanding shares 9615 (9.62K).
Windtree Therapeutics Inc Market Cap History: 2021 to 2025
Windtree Therapeutics Inc's market capitalization history from 2021 to 2025. Data shows growth from $2.40K to $86.53 (0.00% CAGR).
Windtree Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Windtree Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WINTW by Market Capitalization
Companies near Windtree Therapeutics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Windtree Therapeutics Inc by market ranking:
- WGELF (OTCGREY:WGELF): Ranked #38463 globally with a market cap of $305.35K USD.
- Ziccum AB (ST:ZICC): Ranked #38464 globally with a market cap of $305.34K USD ( Skr3.43 Million SEK).
- Investment Friends Capital SE (WAR:IFC): Ranked #38473 globally with a market cap of $303.35K USD ( zł1.26 Million PLN).
- SCANSOURCE (SC3.SG) (STU:SC3): Ranked #38474 globally with a market cap of $303.22K USD ( €295.40K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #38463 | WGELF | OTCGREY:WGELF | $305.35K | $0.03 |
| #38464 | Ziccum AB | ST:ZICC | $305.34K | Skr0.25 |
| #38473 | Investment Friends Capital SE | WAR:IFC | $303.35K | zł5.30 |
| #38474 | SCANSOURCE (SC3.SG) | STU:SC3 | $303.22K | €31.00 |
Windtree Therapeutics Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Windtree Therapeutics Inc's market cap moved from $2.40K to $ 86.53, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $86.53 | +4400.00% |
| 2024 | $1.92 | -88.89% |
| 2023 | $17.31 | -91.00% |
| 2022 | $192.30 | -92.00% |
| 2021 | $2.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Windtree Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.53 USD |
| MoneyControl | $86.53 USD |
| MarketWatch | $86.53 USD |
| marketcap.company | $86.53 USD |
| Reuters | $86.53 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.